Nonspecific biomarkers, such as C-reactive protein (CRP) and procalcitonin, are valuable for assessing the severity of the disease and response to treatment in patients with pneumonia; however, it remains a challenge to distinguish between bacterial and viral infections [3,7,8,9]. This evidence concerns the gene CRP and pneumonia.